LEMAITRE VASCULAR INC — Director's Dealing 2023

Nov 28, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2023-11-27

Reporting Person: O'Connor John James (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-11-27	Common Stock	M	7500	$23.56	Acquired	56454	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-11-27	Stock Option (Right to Buy)	$23.56	M	7500	Disposed	2023-12-19	Common Stock (7500)	Direct

Footnotes

F1: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.

F2: This option is exercisable and vests over a five-year period at a rate of 1/3 on the first anniversary of the date listed in the table, and the balance vests in equal annual installments over the remaining three years.